ACT-335827 is an orally available, selective orexin 1 receptor antagonist with anxiolytic effects in animals.

Unlike other orexin receptor antagonists, ACT-335827 lacks sedative effects and was found to have no impact on sleep architecture in mice.

[1][2]

This article about an anxiolytic is a stub.

You can help Wikipedia by expanding it.